Oxymatrine liposome attenuates hepatic fibrosis via targeting hepatic stellate cells

doi:10.3748/wjg.v18.i31.4199

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 31

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6222)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

456

HTML

5464

Figures (1-4)

161

Tables (1-1)

141

Sum=6222

Aug 21, 2012 (publication date) through Apr 19, 2024

Times Cited of This Article

Times Cited (72)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Aug 21, 2012; 18(31): 4199-4206
Published online Aug 21, 2012. doi: 10.3748/wjg.v18.i31.4199

Full Size Figure Download Figure

Figure 3 Oxymatrine liposomes inhibited fibrosis-related gene expression. The expression of fibrosis-related gene, such as MMP-2, TIMP-1 and collagen I was evaluated by real-time polymerase chain reaction. ^aP < 0.05 vs normal; ^cP < 0.05 vs CCl₄-induced heaptic fibrosis; ^eP < 0.05 vs oxymatrine liposomes. MMP: Matrix metallopeptidase; TIMP: Tissue inhibitor of metalloproteinase; OM: Oxymatrine; RGD: Arg-Gly-Asp.

Citation: Chai NL, Fu Q, Shi H, Cai CH, Wan J, Xu SP, Wu BY. Oxymatrine liposome attenuates hepatic fibrosis via targeting hepatic stellate cells. World J Gastroenterol 2012; 18(31): 4199-4206
URL: https://www.wjgnet.com/1007-9327/full/v18/i31/4199.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i31.4199